Authors:
EICKHOFF TC
WHITE LJ
GULLEN DJ
ADDINGTON W
ALEDORT LM
FRYHOFER SA
JACKSON EB
LURIE N
SAMS BJ
TOOKER JP
WINSLOW CM
CLEAVELAND CR
SAMUELSON CO
BERENSON RA
CASSEL CK
EISENBERG JM
GULLEN DJ
MYERS WA
SCHROEDER SA
SOX HC
THOMSON GE
YOUNG QD
HOLMES KK
ARMSTRONG D
BURKE D
GERBERDING J
HOTH DF
HYSLOP NE
JAFFE HW
MASUR H
PHAIR JP
PIZZO PA
REMINGTON JS
SANDE MA
TRAMONT EC
WILFERT CM
WOFSY CB
SANDE MA
MANDELL GL
ANDRIOLE VT
WILFERT CM
DOUGLAS RG
BULLOCK WE
GOLDSTEIN EJC
KARCHMER AW
MAKI DG
RONALD AR
STAMM WE
Citation: Tc. Eickhoff et al., HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION, Annals of internal medicine, 120(4), 1994, pp. 310-319
Citation: Do. Dixon et al., HIV VACCINE TRIALS - SOME DESIGN ISSUES INCLUDING SAMPLE-SIZE CALCULATION, Journal of acquired immune deficiency syndromes, 6(5), 1993, pp. 485-496
Authors:
VERMUND SH
FISCHER RD
HOFF R
RIDA WN
SHEON AR
LAWRENCE DN
HOTH DF
BARKER LF
Citation: Sh. Vermund et al., PREPARING FOR HIV VACCINE EFFICACY TRIALS - PARTNERSHIPS AND CHALLENGES, AIDS research and human retroviruses, 9, 1993, pp. 190000127-190000132